The European Respiratory Journal, the official journal of the European Respiratory Society, publishes 12 issues in two volumes per year in English.
The ERJ publishes clinical and experimental work relating to all aspects of respiratory medicine, including cell biology, epidemiology, immunology, pathophysiology, thoracic imaging, paediatric pneumology, occupational medicine, intensive care, sleep medicine, thoracic surgery and thoracic oncology. In addition to such original material, the ERJ prints editorials, reviews, series articles, correspondence and letters to the editor.
The ERJ takes part in the HINARI Programme. The HINARI Programme, set up by the World Health Organization together with major publishers, enables developing countries to gain access to collections of biomedical and health literature. Over 6400 journal titles are now available to health institutions in 108 countries, areas and territories, benefiting many thousands of health workers and researchers, in turn contributing to improved world health. For more information about HINARI, go to www.who.int/hinari/en/
All submissions to the ERJ are handled via the ScholarOne Manuscripts platform, which provides detailed instructions of how to follow the submission process. If you experience problems or require any further assistance, please contact the submission helpline direct on +44 114 2672864 or contact Gill Archer, ScholarOne Manuscripts coordinator.
Presentation of manuscripts should be consistent with the Uniform Requirements for Manuscripts Submitted to Biomedical Journals, as recommended by the International Committee of Medical Journal Editors (ICMJE).
All manuscripts must be submitted electronically using the online submission at ScholarOne Manuscripts. Detailed instructions of how to submit are available on the website itself and the process is self explanatory. However, if you do experience problems, please contact the submission helpline direct on +44 114 2672864 or contact Gill Archer, ScholarOne Manuscripts coordinator.
European Respiratory Journal manuscripts should be prepared in accordance with the manuscript preparation guidelines for ERS research publications. These cover manuscript content as well as ethical, authorship and conflict of interest considerations.
Before entering the ERJ ScholarOne online submission area, please read and carefully follow the manuscript preparation guidelines and the information below.
Brief requirements for articles are summarised in the following table. Further details can be found in the manuscript preparation guidelines.
|Article type||Word limit||Figures and tables||References||Online supplement||Abstract|
|Original research||3000||8||40||Accepted||Yes, 200 words|
|Review and series articles||5000||5||200||Accepted||Yes, 200 words|
|Research letters||1200||1||15||Not accepted||No|
|Task force reports, guidelines and consensus statements||8000||15||250||Accepted||Yes, 200 words|
The number of figures and tables in the above summary refers to the total number of both; for example, letters can have either one figure or one table, not one of each.
On submission of your manuscript, you will be notified by e-mail on receipt of the submitted online draft and provided with a manuscript number for future reference.
Each manuscript will be reviewed by the chief editor and associate editors. Because the European Respiratory Journal receives many times more submissions that it can publish, manuscripts that are not regarded as sufficiently original or high in priority may be rejected after review by the editors. We will aim to communicate such a decision to you quickly so you can consider other publication routes for your work.
Manuscripts not rejected at this stage will be subjected to peer review by external reviewers and statistical advisors. After your manuscript has been reviewed, you may be requested to make changes to your manuscript arising from reviewer comments. When submitting your revised manuscript, two copies must be provided: one clean copy of the revised manuscript, and one copy in which all of the text added as a result of reviewer comments is highlighted in red.
The reviewers and associate editors will recommend their decisions to the chief editor, who will then be responsible for the final decision to accept or reject a manuscript.
If your manuscript is rejected after peer review, and you wish to appeal the decision, please e-mail a letter of rebuttal to: [email protected]
In the appeal letter, you should clearly state your name, the title of your manuscript and the manuscript number. Furthermore, it will help us to handle your appeal if you can provide specific point-by-point responses to any comments made by the editors and reviewers in support of their original decision. We will respond to all appeals as soon as possible, but of course in some cases it may take some time to make a final decision. The decision of the chief editor is final and only one appeal will be considered per manuscript.
Submission of the manuscript implies that if and when it is accepted for publication, the authors automatically agree to transfer the copyright to the publisher wherever possible. The copyright transfer implies that the publisher holds the exclusive right to reproduction in any form (including publication in another language) and distribution of any of the articles in the journal. Material published in the European Respiratory Journal may not be stored in any electronic format, or be reproduced photographically, except with the prior written permission of the publisher.
In the event that the paper is accepted for publication, all authors will be contacted and asked to complete an online form transferring copyright to ERS. All authors must complete this online form before the paper can be published.
Further to the transfer of publishing rights to the ERS, authors can opt to make their article open access through the ERJ Open scheme, and are permitted to self-archive their manuscripts after the journal’s embargo period has elapsed.
Full details regarding open access, public archiving and funder mandates can be found in the following section.
What is ERJ Open?
ERJ Open is an optional service offered by the European Respiratory Society that enables authors to ensure that their final published contribution is made available for anyone to access online, immediately on publication. This option is an important part of our response to the changing expectations of authors, readers and funding bodies who support research and scholarly communication. ERJ Open is compliant with the publisher requirements for open access publication set out by Wellcome.
Standard option. The standard ERJ Open service costs €2000. Articles will be published under a Creative Commons Attribution Non-commercial (CC BY-NC) 4.0 copyright licence (creativecommons.org).
Mandated option. A number of funding bodies now mandate that open access articles be published under a Creative Commons Attribution (CC BY) 4.0 copyright licence (creativecommons.org). ERS makes this service available to authors whose funding body requires it, at a cost of €3000. To qualify, the funder must be among those listed at erj.ersjournals.com/authors/cc-by-funders
Payment in EUR is preferred, although other currencies may be permissible subject to contacting our accounts department. The article charge does not cover any other costs associated with publication, e.g. charges for colour printing, about which you would have been be notified when your article was accepted for publication. You will be required to complete and submit an article charge form. Authors may pay the article charge themselves or provide billing details of funders who have agreed to pay on their behalf. If the person or organisation paying the fee is based in the European Union, VAT may be payable. Pre-payment in full is required to activate ERJ Open. If the ERS does not receive payment of the fee, the article will not be published open access.
What happens to an open access paper?
You should submit your paper according to the journal’s instructions for authors and guidance on preparation of manuscripts. Only after your paper is accepted for publication will you be able to request that your paper is published open access; your choice to pay for this open access service will not affect the peer-review process, and payment of an open access fee will not secure preferential treatment.
ERJ Open is available immediately upon online publication (i.e. in ERJ In Press if your article meets the criteria for inclusion in the In Press section) through to final publication (in a print and online monthly issue). All ERJ Open articles will be identified by means of an icon in the table of contents and search results.
In addition, ERJ Open articles will carry the following notice:
©ERS 20XX. ERJ Open articles are open access and distributed under the terms of the Creative Commons Attribution [Non-commercial] Licence 4.0.
The ERS as the publisher will deposit the full text of your article in PubMed Central (PMC) upon final publication.
At this time, the ERS does not allow articles that have already been published to be made open access.
Terms and conditions for ERJ Open papers
It is ERS policy to require copyright assignment for all European Respiratory Journal articles to enable efficient handling of rights, to safeguard authors against plagiarism and infringement and to protect and authenticate the final published version. For more details, please refer to our copyright form.
ERJ Open articles are protected by copyright. Publishing an ERJ Open paper enables legitimate distribution of your work online under the terms of the relevant Creative Commons licence.
ERJ Open articles published with the standard CC BY-NC licence have no restriction on their use, distribution and reproduction in any medium provided it is for non-commercial purposes, and that the original work is properly cited. If a paper is not reproduced in its entirety but only in part, or as a derivative work, this must be clearly stated.
Use of ERJ Open articles published with a standard CC BY-NC licence for commercial, promotional or marketing purposes requires further explicit permission from ERS ([email protected]) and may be subject to a fee. Commercial purposes include:
- copying or downloading articles, for further redistribution, sale or licensing;
- copying, downloading or posting by a site or service that incorporates advertising with such content;
- the inclusion or incorporation of article content in other works or services that are then available for sale or licensing, for a fee;
- use of article content by for-profit organisations for promotional purposes;
- use for the purposes of monetary reward by means of sale, resale, licence, loan, transfer or other form of commercial exploitation such as marketing products.
ERJ Open articles published with the mandated CC BY licence have no restriction on their use, distribution and reproduction in any medium provided that the original work is properly cited.
Print reprints and eprints of ERJ Open articles can be purchased from [email protected]
If you decide to publish your article with one of our open access licences and pay the article processing charge outlined above, you will be eligible for a refund if:
1. We publish your article with an incorrect licence, and we fail to correct and republish the article within 1 month of you having informed us of the error;
2. We fail to deposit your article to PMC within 2 months of final publication of the article on our own website; or
3. We fail to publish an author correction or erratum concerning your article within 2 months of you having informed us of the error, subject to our agreement that the reported correction necessitates correction and republication of the article, per our usual policies.
“Green” open access and author archiving
Authors who do not wish to pay for the ERJ Open option will still have their manuscripts made free to access via the ERJ online archive following the journal’s 18-month embargo period; after this embargo period, authors also have licence to deposit their manuscripts in an institutional (or other) repository for public archiving, provided the following requirements are met:
1) The final, peer-reviewed, author-submitted version that was accepted for publication is used (before copy-editing and publication).
2) A permanent link is provided to the version of the article published in the ERJ, through the dx.doi.org platform. For example, if your manuscript has the DOI 10.1183/09031936.00123412, then the link you provide must be dx.doi.org/10.1183/09031936.00123412
3) The repository on which the manuscript is deposited is not used for systematic distribution or commercial sales purposes.
4) The following required archiving statement appears on the title page of the archived manuscript: “This is an author-submitted, peer-reviewed version of a manuscript that has been accepted for publication in the European Respiratory Journal, prior to copy-editing, formatting and typesetting. This version of the manuscript may not be duplicated or reproduced without prior permission from the copyright owner, the European Respiratory Society. The publisher is not responsible or liable for any errors or omissions in this version of the manuscript or in any version derived from it by any other parties. The final, copy-edited, published article, which is the version of record, is available without a subscription 18 months after the date of issue publication.”
Manuscripts funded by NIH or Europe PubMed Central Funders Group members
The European Respiratory Journal now has in place an author-pays open access scheme, ERJ Open (see above). For authors of manuscripts funded by the National Institutes of Health (NIH) or Europe PubMed Central Funders Group members who do not wish to take up this option, the following allowances apply, in addition to the author archiving policy outlined above.
For manuscripts with NIH or Europe PMC funding, the journal acknowledges that the author retains the right to provide a copy of the final, peer-reviewed author-supplied manuscript (before copy-editing and publication) for public archiving in PubMed Central in compliance with the requirements of the funder, i.e. 12 months after the final publication date for authors with funding from the NIH, and 6 months after final publication for authors with funding from Europe PubMed Central Funders Group members.
Other funder mandates
If your research body mandates an access or archiving model that is not addressed above, please contact [email protected]
Unless requested otherwise, original articles, reviews, series articles and research letters accepted for publication will be published online before they appear in a printed issue of the European Respiratory Journal. Proofs posted online as ERJ In Press articles may be subject to minor changes before final publication in a print issue of the journal.
Accepted manuscripts deemed to be of educational value are submitted to EBAP (the European Board for Accreditation in Pneumology) for accreditation as Continuing Medical Education (CME) articles. European Respiratory Journal readers then have the chance to earn CME credits by reading such articles and correctly answering a selection of multiple choice questions about the manuscript in question.
If your article is deemed to be of educational value, upon acceptance for publication, you may be asked to provide four to six multiple-choice questions to be published with the article. Prompt composition of such questions will enable the timely publication of the article and the ERJ.
From January 1, 2010, CME credits will be free of charge. For more information, visit the CME page.
After your paper is accepted: getting the most out of your publication
After your manuscript is accepted for publication in the European Respiratory Journal, it will be passed to the ERS publications office for copyediting and typesetting before being published. The staff will contact you regarding copyright assignment, and will send you a proof of your article along with any queries that have arisen during our production processes.
Once published online, selected papers will be promoted by the ERS communications department, through press releases, ERS marketing channels or social media. If your own institution is carrying out press activity around your paper, please let us know. The ERS has also created an authors’ guide to using social media to gain exposure and feedback.
If you have further ideas and would like help promoting your work, please contact the editorial office: [email protected]
For the Chinese version click here
For the Spanish version click here
European Respiratory Journal instructions for authors, July 2016.
This page was updated on 1 July, 2016